Cefetamet pivoxil

Drug Profile

Cefetamet pivoxil

Alternative Names: Cefyl; Globocef; RO 158075

Latest Information Update: 08 Aug 2007

Price : $50

At a glance

  • Originator Takeda
  • Developer Roche; Takeda
  • Class Antibacterials; Cephalosporins; Small molecules
  • Mechanism of Action Cell wall inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Bacterial infections

Most Recent Events

  • 08 Aug 2007 Discontinued - Phase-I for Bacterial infections in USA (PO)
  • 12 Jun 2000 Profile reviewed but no significant changes made
  • 24 Nov 1997 Launched for Bacterial infections in Indonesia (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top